What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 3 minute read Pharma Industry News OS Therapies’ OST-HER2 achieves milestone in osteosarcoma treatment OS Therapies, Inc., a clinical-stage biotechnology company, has announced data from its Phase 2b trial of OST-HER2, an… byPallavi MadhirajuJanuary 15, 2025